Monday, 26 October 2026European Markets

SOCIETE GENERALE, VAN DE VELDE, Another 2 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - societe generale (gle.pa), van de velde (van.br), solvac nom(retail) (solv.br) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
societe generale (gle.pa) 7.13% 2023-06-09 07:03:27
van de velde (van.br) 6.9% 2023-06-09 04:17:08
solvac nom(retail) (solv.br) 5.17% 2023-06-09 04:16:41
storebrand (stb.ol) 4.59% 2023-06-09 04:34:17

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. societe generale (gle.pa)

7.13% foward dividend yield

societe generale's last close was €22.88, 19.41% below its 52-week high of €28.39. intraday change was 2.56%.

société générale société anonyme provides banking and financial services to individuals, businesses, and institutional investors in europe and internationally. it operates through french retail banking, international retail banking & financial services, and global banking and investor solutions. it offers retail banking services, such as consumer credit, vehicle leasing and fleet management, online banking, wealth management services, and equipment and vendor finance under the societe generale, credit du nord, and boursorama brand names; and insurance products, including home, vehicle, family, health, and mortgage insurance. the company also provides corporate and investment banking, securities, business consulting, consumer finance, advisory and financing, and asset management and private banking services. in addition, it offers brokerage, cash management, payment, factoring, export financing, and supply chain financing services. société générale société anonyme was incorporated in 1864 and is headquartered in paris, france.

earnings per share

as for profitability, societe generale has a trailing twelve months eps of €1.62.

pe ratio

societe generale has a trailing twelve months price to earnings ratio of 14.48. meaning, the purchaser of the share is investing €14.48 for every euro of annual earnings.

volume

today's last reported volume for societe generale is 1699160 which is 67.63% below its average volume of 5249850.

sales growth

societe generale's sales growth is negative 4.6% for the ongoing quarter and negative 0.4% for the next.

more news about societe generale.

2. van de velde (van.br)

6.9% foward dividend yield

van de velde's last close was €33.25, 13.64% under its 52-week high of €38.50. intraday change was 1.05%.

van de velde nv, together with its subsidiaries, designs, develops, manufactures, and markets fashionable luxury lingerie and swimwear for women worldwide. it operates through two segments, business to business (b2b) and direct to consumer (d2c). the company offers its products under the primadonna, marie jo, andres sarda, and lingerie styling brands. it also operates retail websites; stores; and boutiques and department stores. the company was founded in 1919 and is headquartered in schellebelle, belgium. van de velde nv is a subsidiary of van de velde holding nv.

earnings per share

as for profitability, van de velde has a trailing twelve months eps of €2.81.

pe ratio

van de velde has a trailing twelve months price to earnings ratio of 11.96. meaning, the purchaser of the share is investing €11.96 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.23%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, van de velde's stock is considered to be overbought (>=80).

more news about van de velde.

3. solvac nom(retail) (solv.br)

5.17% foward dividend yield

solvac nom(retail)'s last close was €114.00, 2.56% under its 52-week high of €117.00. intraday change was 0.88%.

solvac s.a. operates as an advanced materials and specialty chemicals company in belgium. the company offers specialty polymers, composite materials, soda ash, peroxides, and silica. solvac s.a. was incorporated in 1983 and is headquartered in brussels, belgium.

earnings per share

as for profitability, solvac nom(retail) has a trailing twelve months eps of €28.04.

pe ratio

solvac nom(retail) has a trailing twelve months price to earnings ratio of 4.1. meaning, the purchaser of the share is investing €4.1 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.46%.

moving average

solvac nom(retail)'s value is above its 50-day moving average of €110.92 and above its 200-day moving average of €105.34.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, solvac nom(retail)'s stock is considered to be oversold (<=20).

volatility

solvac nom(retail)'s last week, last month's, and last quarter's current intraday variation average was 0.89%, 0.11%, and 1.57%.

solvac nom(retail)'s highest amplitude of average volatility was 0.89% (last week), 1.38% (last month), and 1.57% (last quarter).

yearly top and bottom value

solvac nom(retail)'s stock is valued at €115.00 at 22:50 est, below its 52-week high of €117.00 and way higher than its 52-week low of €88.20.

more news about solvac nom(retail).

4. storebrand (stb.ol)

4.59% foward dividend yield

storebrand's last close was kr82.50, 7.05% below its 52-week high of kr88.76. intraday change was 0.17%.

storebrand asa, through its subsidiaries, primarily provides insurance products and services in norway, the united states, japan, and sweden. the company operates through four segments: savings, insurance, guaranteed pension, and other. the savings segment offers retirement savings, defined contribution pensions, asset management, and retail banking products. the insurance segment provides health insurance, property and casualty insurance, personal risk products, and employee-related and pension-related insurance products. the guaranteed pension segment offers long-term pension savings products, such as defined contribution pensions, paid-up policies, and individual capital and pension insurance products. the other segment provides life insurance products. the company also offers securities, and banking and investment services. it serves private individuals, corporate and retail markets, companies, municipalities, and public sector. storebrand asa was founded in 1767 and is headquartered in lysaker, norway.

earnings per share

as for profitability, storebrand has a trailing twelve months eps of kr5.21.

pe ratio

storebrand has a trailing twelve months price to earnings ratio of 15.86. meaning, the purchaser of the share is investing kr15.86 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.93%.

earnings before interest, taxes, depreciation, and amortization

storebrand's ebitda is -14.01.

more news about storebrand.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com